Use of non-steroidal anti-inflammatory drugs in the treatment of bacterial respiratory tract infections of lambs
Keywords:Bacterial pneumonia, Lamb, NSAIDs, Treatment
Respiratory tract infections, which are common in sheep farming, involve interactions between the host's immune system, pathogenic microorganisms such as viruses, bacteria, parasites and environmental conditions. Respiratory diseases can affect sheep of any age and breed. However, acute bacterial and viral pneumonia is most common in those aged three to twelve months due to decreased maternal antibody titers. Although lower respiratory tract infections initially started as a condition caused by a single agent, many cases progress to a complex disease involving both bacterial and viral components, making the diagnosis of the disease complicated by the emergence of secondary infections. Although the inflammatory reaction that occurs in respiratory infections is part of the normal healing process, an extreme reaction can impair healing and severely damage the airways. It is optimal to limit the inflammatory reaction by removing the harmful agent, isolating the damaged tissue, and controlling this tissue. In cases of death due to acute pneumonia, antibiotic drugs are used to prevent further deaths and to treat the herd. It has been found that NSAIDs reduce the release of toxic peroxide which causes the proliferation of fibroblasts and the deposition of collagen in inflammatory processes associated with the respiratory tract. It had been reported that clinical findings improve more rapidly when NSAIDs (non-steroidal anti-inflammatory drugs) were used together with antibiotics in respiratory system infections. In this review, the importance of using NSAIDs in the respiratory tract infections of sheep has been mentioned.
Chakraborty S, Kumar A, Tiwari R, Rahal A, Malik Y, Dhama K, et al. Advances in diagnosis of respiratory diseases of small ruminants. Veterin Med Int. 2014:508304.
Lacasta D, Ferrer L, Ramos J, González J, Heras MDL. Influence of climatic factors on the development of pneumonia in lambs. Small Ruminant Res. 2008;80(1-3):28-32.
Bell S. Respiratory disease in sheep. In Pract. 2008;30(4):200.
Radostits OM, Gay CC, Hinchcliff KW, Constable PD. Veterinary Medicine E-Book: A textbook of the diseases of cattle, horses, sheep, pigs and goats. 10th ed. Elsevier Health Sciences; 2006.
Ettorre C, Sacchini F, Scacchia M, Salda LD. Pneumonia of lambs in the Abruzzo region of Italy: anatomopathological and histopathological studies and localisation of Mycoplasma ovipneumoniae. Vet Ital. 2007;43(1):149-55.
Bednarek D, Szymańska-Czerwińska M, Dudek K. Bovine respiratory syndrome (BRD) etiopathogenesis, diagnosis and control. Bird Eye View Veterin Med. 2012:363-78.
Weerdt MVD, Coghe J, Uystepruyst C, Deby-Dupont G, Lekeux P. Ketoprofen and phenylbutazone attenuation of PAF-induced lung inflammation in calves. Veterin J. 1999;157(1):39-49.
Bednarek D, Kondracki M, Friton G, Trela T, Niemczuk K. Effect of steroidal and non-steroidal anti-inflammatory drugs on inflammatory markers in calves with experimentally-induced bronchopneumonia. Berliner Munchener tierarztliche Wochenschrift. 2005;118(7-8):305-8.
Bednarek D, Zdzisinska B, Kondracki M, Kandefer-Szerszen M. Effect of steroidal and non-steroidal anti-inflammatory drugs in combination with long-acting oxytetracycline on non-specific immunity of calves suffering from enzootic bronchopneumonia. Vet Microbiol. 2003;96(1):53-67.
Lockwood P, Johnson J, Katz T. Clinical efficacy of flunixin, carprofen and ketoprofen as adjuncts to the antibacterial treatment of bovine respiratory disease. Vet Rec. 2003;152(13):392-4.
Weingarten A. Mechanisms of action and the role of anti-pyretic and antiinflammatory intervention in the treatment of bovine respiratory disease. Getting it right the first time: best practices in BRD treatment. EBF Marseille. 2009:6-15.
Alley MR. Pneumonia in sheep in New Zealand: an overview. N Z Vet J. 2002;50 (3):99-101.
Gilmour NJ. Pasteurella haemolytica infections in sheep. Vet Quarterly. 1980;2(4):191-8.
Tabatabaei M, Abdollahi AF. Isolation and identification of Mannheimia haemolytica by culture and polymerase chain reaction from sheep's pulmonary samples in Shiraz, Iran. Vet World. 2018;11(5):636-41.
Iovane G, Galdiero M, Vitiello M, DeMartino L. Effect of Pasteurella haemolytica outer membrane proteins on bovine neutrophils. FEMS Immunol Med Microbiol. 1998;20(1):29-36.
Mohamed R, Abdelsalam E. A review on pneumonic pasteurellosis (respiratory mannheimiosis) with emphasis on pathogenesis, virulence mechanisms and predisposing factors. Bulgar J Veterin Med. 2008;11(3):139-60.
Brogden KA, Lehmkuhl HD, Cutlip RC. Pasteurella haemolytica complicated respiratory infections in sheep and goats. Veterin Res. 1998;29(3-4):233-54.
Fernandez S, Galapero J, Gomez L, Perez C, Ramos A, Cid D, et al. Identification, capsular typing and virulence factors of Pasteurella multocida isolates from Merino lambs in Extremadura (Southwestern Spain). Veterinární Medicína. 2018;63(3):117-24.
Angen O, Ahrens P, Kuhnert P, Christensen H, Mutters R. Proposal of Histophilus somni gen. nov., sp. nov. for the three species incertae sedis 'Haemophilus somnus', 'Haemophilus agni' and 'Histophilus ovis'. Int J Syst Evol Microbiol. 2003;53(5):1449-56.
Headley SA, Pereira AHT, Balbo LC, DiSantia GW, Bracarense A, Filho L, et al. Histophilus somni-associated syndromes in sheep from Southern Brazil. Brazil J Microbiol. 2018;49 (3):591-600.
Walker R, Biberstein E, Pritchett R, Kirkham C. Deoxyribonucleic acid relatedness among “Haemophilus somnus,” “Haemophilus agni,” “Histophilus ovis,” “Actinobacillus seminis,” and Haemophilus influenzae. Int J Systemat Evolution Microbiol. 1985;35(1):46-9.
Chen W, Alley M, Manktelow B. Pneumonia in lambs inoculated with Bordetella parapertussis: clinical and pathological studies. N Z Vet J. 1988;36(3):138-42.
Porter JF, Connor K, Donachie W. Isolation and characterization of Bordetella parapertussis-like bacteria from ovine lungs. Microbiology (Reading). 1994;140(2):255-61.
Lindmark H, Nilsson M, Guss B. Comparison of the fibronectin-binding protein FNE from Streptococcus equi subspecies equi with FNZ from S. equi subspecies zooepidemicus reveals a major and conserved difference. Infect Immun. 2001;69(5):3159-63.
Efstratiou A, Colman G, Hahn G, Timoney J, Boeufgras J, Monget D. Biochemical differences among human and animal streptococci of Lancefield group C or group G. J Med Microbiol. 1994;41(2):145-8.
Stevenson R. Streptococcus zooepidemicus infection in sheep. Can J Comp Med. 1974;38(3):243-50.
Wang Q, Fidalgo S, Chang B, Mee B, Riley T. The detection and recovery of Erysipelothrix spp. in meat and abattoir samples in Western Australia. J Appl Microbiol. 2002;92(5):844-50.
Ersdal C, Jørgensen H, Lie KI. Acute and chronic Erysipelothrix rhusiopathiae infection in lambs. Vet Pathol. 2015;52(4):635-43.
Kuehn NF. Principles of Therapy of Respiratory Disease. Available at: https://www.msdvetmanual.com/respiratory-system/respiratory-system-introduction/principles-of-therapy-of-respiratory-disease. Accessed on 5 June 2021.
Lekeux P. A therapeutic strategy for treatment of the bovine respiratory disease complex: The rationale for the combination of a nonsteroidal anti-inflammatory drug with an antibiotic. Cattle Pract. 2007;15(2):115-9.
Scott PR. Treatment and control of respiratory disease in sheep. Vet Clinic North Am. 2011;27(1):175-86.
Wernicki A, Stachura R, Hola P, Puchalski A, Dec M, Stegierska D, et al. Efficacy of florfenicol and flunixin followed with vitamin E and/or C on selected oxidative and inflammatory mechanisms in young cattle under transport and adaptation stress. Medycyna Weterynaryjna. 2018;74(4).
Urban-Chmiel R, Stachura R, Hola P, Puchalski A, Dec M, Wernicki A. Effects of flunixin and florfenicol combined with vitamins E and/or C on selected immune mechanisms in cattle under conditions of adaptive stress. Bull Vet Instit Pulawy. 2015;59(2):295-301.
Ekstrand‐Hammarström B, Österlun C, Lilliehöök B, Bucht A. Vitamin E down‐modulates mitogen‐activated protein kinases, nuclear factor‐κB and inflammatory responses in lung epithelial cells. Clinic Experiment Immunol. 2007;147(2):359-69.
Cheallaigh CN, Keane J, Lavelle EC, Hope JC, Harris J. Autophagy in the immune response to tuberculosis: clinical perspectives. Clinic Experiment Immunol. 2011;164(3):291-300.
Rehman P. Sub-clinical rickets and recurrent infection. J Tropic Pediatr. 1994;40(1):58.
Yim S, Dhawan P, Ragunath C, Christakos S, Diamond G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1, 25-dihydroxyvitamin D3. J Cystic Fibrosis. 2007;6(6):403-10.
Edwards T. Control methods for bovine respiratory disease for feedlot cattle. Vet Clinic Food Animal Pract. 2010;26(2):273-84.
Cusack P, McMeniman N, Lean I. The medicine and epidemiology of bovine respiratory disease in feedlots. Austral Veterin J. 2003;81(8):480-7.
EMEA. The European agency for the evaluation of medicinal products veterinary medicines evaluation unit. committee for veterinary medicinal products. Clenbuterol Summ Rep. 2000;2:1-6.
Gilmour N, Sharp J, Gilmour J. Effect of oxytetracycline therapy on experimentally induced pneumonic pasteurellosis in lambs. Vet Rec. 1982111(5):97-9.
Sargison N, Scott P. Evaluation of antibiotic treatment of respiratory disease, including suspected septicemic pasteurellosis in five-week-old lambs. Agri Pract (USA). 1995.
Godinho K, Benchaoui H, Tilt N, Ramage C, Quirie M, Donachie W, et al. Efficacy of danofloxacin in the treatment of pneumonic pasteurellosis in specific pathogen-free lambs. British Medical Journal Publishing Group; 2007.
Naccari F, Pellegrino M, Calò M, Licata P, Giofré F, Carli S. Effectiveness and kinetic behaviour of tilmicosin in the treatment of respiratory infections in sheep. Vet Rec. 2001;148(25):773-6.
Gonzalez J, Lacasta D, Ferrer L, Figueras L, Abadie G, Heras MDL. Mannheimia haemolytica and Bibersteinia trehalosi serotypes isolated from lambs with ovine respiratory complex in Spain. J Hellenic Vet Med Soc. 2013;64(3):177-82.
Lacasta D, Ferrer L, Ramos J, González J, Ortín A, Fthenakis G. Vaccination schedules in small ruminant farms. Vet Microbiol. 2015;181(1-2):34-46.
Lehmkuhl H, Cutlip R. Protection from parainfluenza-3 virus and persistence of infectious bovine rhinotracheitis virus in sheep vaccinated with a modified live IBR-PI-3 vaccine. Canadian J Comp Med. 1985;49(1):58.
Buer JK. Origins and impact of the term ‘NSAID’. Inflammopharmacol. 2014;22(5):263-7.
Lascelles BDX, McFarland JM, Swann H. Guidelines for safe and effective use of NSAIDs in dogs. Vet Therapeut. 2005;6(3):237.
Curry SL, Cogar SM, Cook JL. Nonsteroidal antiinflammatory drugs: a review. J Am Animal Hospit Assoc. 2005;41(5):298-309.
Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscleros Thrombos Vascul Biol. 2011;31(5):986-1000.
Brune K, Patrignani P. New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Res. 2015;8:105.
Rao P, Knaus EE. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharmaceut Sci. 2008;11(2):81-110.
Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacolog Rev. 2004;56(3):387-437.
Kim SJ, Flach AJ, Jampol LM. Nonsteroidal anti-inflammatory drugs in ophthalmology. Survey Ophthalmol. 2010;55(2):108-33.
Brater DC. Clinical pharmacology of NSAIDs. J Clinic Pharmacol. 1988;28(6):518-23.
Stockley RA. Role of inflammation in respiratory tract infections. Am J Med. 1995;99(6):8-13.
Cone JB. Inflammation. Am J Surg. 2001;182(6):558-62.
Lekeux P. BRDC and the modulation of lung inflammation. Veterinary J. 2006.
Endo T, Ogushi F, Kawano T, Sone S. Comparison of the regulations by Th2-type cytokines of the arachidonic-acid metabolic pathway in human alveolar macrophages and monocytes. Am J Respirat Cell Molecul Biol. 1998;19(2):300-7.
Frölich J. A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes. Trend Pharmacol Sci. 1997;18(1):30-4.
Takashiba S, Dyke TEV, Shapira L, Amar S. Lipopolysaccharide-inducible and salicylate-sensitive nuclear factor(s) on human tumor necrosis factor alpha promoter. Infect Immun. 1995;63(4):1529-34.
Vassalli P. The pathophysiology of tumor necrosis factors. Ann Rev Immunol. 1992;10(1):411-52.
Shackelford RE, Alford B, Xue Y, Thai SF, Adams DO, Pizzo S. Aspirin inhibits tumor necrosis factoralpha gene expression in murine tissue macrophages. Mol Pharmacol. 1997;52(3):421-9.